Statistics from Altmetric.com
- PHARMACY MANAGEMENT (ORGANISATION, FINANCIAL)
- PHARMACY MANAGEMENT (PERSONNEL)
- STATISTICS & RESEARCH METHODS
- HEALTH SERVICES ADMINISTRATION & MANAGEMENT
The voting system for the summit was developed with two major aims: first to keep a balance between the groups and second to differentiate the levels of agreement in order to identify implementation priorities.
As the European Association of Hospital Pharmacists (EAHP) has 34 members, each with a vote, first it was necessary to weight the votes of patient groups and other healthcare professionals (HCP; ie, physicians and nurses) to achieve a 50:25:25 balance. Each association attending the summit had one delegate. Thus pharmacists had a total 34 votes, while patients and HCP had 17 each. The aim was to avoid one group overruling another through numerical superiority. As 31 EAHP members ultimately attended the summit, this proportion was changed to 31:15.5:15.5. The weighting factor was calculated with the formula:
As 12 patient groups attended the summit, their vote was weighted by
And as seven HCP associations attended the summit, their vote was weighted by
In this way it was impossible for pharmacists to overrule the decisions of patients and HCP just because they were in a majority.
Voting on a statement was only valid if at least 90% of the delegates expressed their opinion. Thus, out of the 31+12+7=50 delegates, at least 45 had to vote. A quorum was achieved for all statements and for 34 statements (77%) all delegates voted.
The delegates voting had four choices: strongly agreed, agreed, disagreed and strongly disagreed. Each possibility was weighted by points ranging from +2 (strongly agreed) to −1 (strongly disagreed).
Strong agreement was defined as ≥85% of the maximum number of points, that is, 85% of the points achievable if all voting delegates had strongly agreed:
Agreement was defined as ≥85% of the number of points achievable if all delegates had agreed:
For both these levels of agreement, the maximum number of points was reduced for the 10 statements where some delegates abstained.
During the Delphi process, it was intended to review any statements with between 34 and 58 points, but in practice this system was not used as changes were also made by agreement in order to optimise the wording. At the summit, statements with less than 53 points would have failed but this did not happen due to the intensive Delphi process.
Votes were anonymous, but the three groups (pharmacists, patients and HCP) were identified by the different frequency channels of the voting devices they used. This was necessary in order to calculate the results.
All detailed results and parameters are available online.1 The voting system was explained to all participants by written information before the summit and was described again at the beginning of the summit to make sure that all delegates were aware of the system and understood it. No objections were made.
Summit Participants List
Gunar Stemer, Austrian Association of Hospital Pharmacists
Claudine Ligneel, Vlaamse vereniging van ziekenhuisapothekers (VZA)
Sophie Lorent, Association francophone des pharmaciens hospitaliers de Belgique (AFPHB)
Velina Grigorova, Bulgarian Association of Hospital Pharmacists
Kota Miroslav, Croatian Pharmaceutical Society–Hospital Pharmacy Section
Marek Lzicar, Czech Association of Hospital Pharmacists
Kirsten Lykke Vorbeck, Pharmadanmark – Hospital
Marika Saar, Estonian Society of Hospital Pharmacists
Carita Linden-Lahti, The Finnish Pharmacist's Association
Niccolo Curatolo, European Fellowship for Pharmacists
Former Yugoslav Republic of Macedonia (F.Y.R.O.M)
Biljana Lazarova, Pharmaceutical Chamber of Macedonia
Steffen Amann, ADKA – The German Society of Hosptial Pharmacists
Despina Makridaki, Panhellenic Association of Hospital Pharmacists
András Süle, Hungarian Society of Hospital Pharmacists
Thorunn Kristin Gudmundsdottir, Pharmaceutical Society of Iceland, Hospital Pharmacy Section
Nuala Doyle, Hospital Pharmacists Association of Ireland (HPAI)
Simona Creazzola, Società Italiana di Farmacia Ospedaliera (SIFO)
Inese Sviestina, The Pharmacist's Society of Latvia
Sylvain Rodenbach, Association des Pharmaciens Hospitaliers Luxembourgeois
Julie Schelinsky, Association des Pharmaciens Hospitaliers Luxembourgeois
Valerie Vella, Malta Association of Hospital Pharmacy
Frank Jorgensen, Norwegian Association of Hospital Pharmacists
Maria Helena Farinha Martins, The Portuguese Association of Hospital Pharmacists (APFH)
The Polish Pharmaceutical Chamber awarded a proxy vote to the Czech Association of Hospital Pharmacists.
Paul Andreianu, The National Association of Hospital Pharmacists from Romania (ANFSR)
Nenad Miljkovic, Pharmaceutical Association of Serbia
Adriana Durcanska, Slovak Pharmaceutical Chamber
Franci Tratar, Slovenian pharmaceutical society – Section of hospital pharmacists
Sari Frigård, Swedish Association of Pharmaceutical Sciences Section for Hospital Pharmacy
Magnus Munge, Swedish Association of Pharmaceutical Sciences Section for Hospital Pharmacy
Priska Vonbach, Swiss Association of Public Health Administration and Hospital Pharmacists (GSASA)
Arnold Vulto, Dutch Association of Hospital Pharmacists (NVZA)
The Turkish Hospital Pharmacists Section awarded a proxy vote to the Panhellenic Association of Hospital Pharmacists
David Miller, The Guild of Healthcare Pharmacists (GHP)
Graeme Richardson, The Guild of Healthcare Pharmacists
Laura Savini of the European Haemophilia Consortium attended the first day of the Summit and awarded a proxy vote to Rare Diseases Europe (Eurordis) for the second day.
Laurent Louette of the European Heart Network attended the first day of the Summit and awarded a proxy vote to the European Public Health Alliance (EPHA) for the second day.
European Patients' Forum awarded a proxy vote to Rare Diseases Europe (Eurordis)
Yves Brand of the European Multiple Sclerosis Platform attended the first day of the Summit and award a proxy vote to European Aids Treatment Group for the second day.
Luc Matthysen, Rare Diseases Europe (Eurordis)
Giorgio Barbareschi and Mariana Vicente, The European Aids Treatment Group
Mihaela Militaru, The European Cancer Patient Coalition
Cathalijne Van Doorne, The European Federation of Neurological Associations
Hildrun Sundseth, The European Institute of Women's Health
Heather Clarke, The European Parkinson's Disease Association
Sascha Marschang, The European Public Health Alliance
Katie Gallagher, The International Diabetes Federation (Europe)
Healthcare Professional Representatives
Antony Bertrand, European Association of Senior Physicians
Marianne de Visser, European Federation of Neurological Societies
Dominique Bron, European Haematology Association
The European Nurses in Diabetes (FEND) awarded a proxy vote to European Specialist Nurses Organisations.
The European Oncology Nursing Society awarded a proxy vote to European Specialist Nurses Organisations.
Ber Oomen, European Specialist Nursing Organisations
Patricia Messmer, The Council of International Neonatal Nurses
EAHP Board Members
Roberto Frontini, EAHP President
Tajda Miharija-Gala, EAHP Vice President
Tony West, Director of Finances
Joan Peppard, Director of Professional Development (EAHP President-Elect)
Cees Neef, Director of Education, Science and Research
Aida Batista, Director of Professional Development
Juraj Sykora, Director of Professional Development
Francesca Venturini, Director of Professional Development Apologies were received from Petr Horák, Director of Professional Development.
Observers (NON VOTING PARTICIPANTS)
David Witmer, American Society of Health Systems Pharmacists
Frederik Ulrichs, Baxter
Gery Demeusy, Carefusion
Silvia Ravera, Council of Europe–European Directorate for the Quality of Medicines and HealthCare (EDQM)
Ulrike Mayer, Employed Community Pharmacists in Europe
Serge Caillier, Employed Community Pharmacists in Europe
Joao Jose Joaquim, European Association of Pharmacy Technicians
Carlos Miguel Figueira, European Association of Pharmacy Technicians
Phil Wiffen, European Journal of Hospital Pharmacy
Björn Ellger, European Patient Safety Foundation
Tiia Metiäinen, European Pharmaceutical Students Association
Jorge Batista, European Pharmaceutical Students Association
Olga Kozhaeva, European Society of Paediatric Oncology
Marianne Ivey, International Pharmaceutical Federation (FIP)
Rob Moss, International Pharmaceutical Federation (FIP)
Jacqueline Surugue, International Pharmaceutical Federation (FIP)
Gysbrecht Goossens, Pfizer
Claus Hemmingsen, Pfizer
Yves Prevoo, Pfizer
Jamie Wilkinson, Pharmaceutical Group of the European Union (PGEU)
Jan Smits, Pharmaceutical Group of the European Union (PGEU)
Constance Colin, The Standing Committee of European Doctors
Roberta Savli and Jelena Malinina, The European Federation of Allergy and Airways Diseases Patients' Associations
Jennie De Greef, Chief Operating Officer
Richard Price, Policy & Advocacy Officer
David Preece, Research Assistant
Taviana Caminiti, Events Coordinator
Martina De Gregorio, Events Assistant
Sandra Teixeira, Executive Assistant–Business Development
Elizabeth Van Staeyen, Sponsorship Coordinator
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.